Skip to main content

Advertisement

Log in

Patient-centered measures for achalasia

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

Various instruments may be used to measure health-related quality of life in patients with achalasia.

Methods

We administered four patient-centered measures used for evaluation of achalasia severity [an achalasia severity questionnaire we developed previously, an achalasia symptom checklist, the Gastrointestinal Quality-of-Life Index (GIQLI), and the Medical Outcomes Study 36-item Short-Form survey (SF-36)] to 25 subjects enrolled in a randomized controlled trial comparing pneumatic dilatation and laparoscopic Heller myotomy. We estimated correlations between the different measures.

Results

Twenty-five patients (13 male, 12 female) were studied; 12 were treated by pneumatic dilatation and 13 by laparoscopic myotomy. The average age of patients was 48.5 [range 25–69, standard deviation (SD) 13.7] years. Baseline scores demonstrated a substantial burden of impairment. The mean (SD) score on the achalasia severity measure [ranges from 0 (best) to 100 (worst)] was 62.3 (13.4). The mean (SD) symptom checklist score [ranges from 0 (best) to 36 (worst)] was 23.2 (6.6). The mean (SD) GIQLI [ranges from 0 (worst) to 144 (best)] was 77.04 (19.4). The SF-36 mean (SD) for the physical component score (PCS) was 45.29 (9.21) and the mean for the mental component score (MCS) was 37.61 (14.97). The achalasia severity measure correlated highly with the GIQLI (r = −0.57, p = 0.01), and the symptom checklist (r = 0.65, p = 0.004). The achalasia severity measure correlated well with the SF-36 PCS (r = −0.42, p = 0.039), but not with the MCS (r = −0.14, p = 0.501).

Conclusion

Subjects recruited to a randomized controlled trial of achalasia treatment demonstrated impairment in both generic quality-of-life and disease-specific measures. Scores on achalasia-specific measures correlated well with each other, but less well with measures of generic quality-of-life and mental health scales. Because of the multidimensional nature of achalasia, disease-specific measures should be combined with generic health measures for the best assessment of patient outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Revicki DA, Wood M, Wiklund I, Crawley J (1998) Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease. Qual Life Res 7:75–83

    Article  PubMed  CAS  Google Scholar 

  2. Damiano A, Handley K, Adler E, Siddique R, Bhattacharyja A (2002) Measuring symptom distress and health-related quality of life in clinical trials of gastroesophageal reflux disease. Dig Dis Sci 47:1530–1537

    Article  PubMed  Google Scholar 

  3. Urbach DR, Tomlinson GA, Harnish JL, Martino R, Diamant NE (2005) A measure of disease-specific health-related quality of life for achalasia. Am J Gastroenterol 100:1–9

    Article  Google Scholar 

  4. Eypasch E, Williams JI, Wood-Dauphinee S, Ure BM, Schmulling C, Neugebauer E, Troidl H (1995) Gastrointestinal quality of life index: Development, validation and application of a new instrument. Br J Surg 82:216–222

    Article  PubMed  CAS  Google Scholar 

  5. McHorney CA, Ware JE, Raczek AE (1993) The MOS 36-item short-form health survey (SF-36): II psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31:247–263

    Article  PubMed  CAS  Google Scholar 

  6. Ware JE, Kosinski M (2001) SF-36 Physical and mental health summary scales: A manual for users of version 1 (2nd Edition). QualityMetric Inc., Lincoln, RI

    Google Scholar 

  7. Dakkak M, Bennett JR (1992) New dysphagia score with objective validation. J Clin Gastroenterol 14:99–100

    Article  PubMed  CAS  Google Scholar 

  8. Wills VL, Hunt DR (2001) Functional outcome after Heller myotomy and fundoplication for achalasia. J Gastrointest Surg 5:408–413

    Article  PubMed  CAS  Google Scholar 

  9. West RL, Hirsch DP, Bartelsman JFWM, De Borst J, Ferwerda G, Tytgat GNJ, Boeckxstaens GE (2002) Long-term results of pneumatic dilatation in achalasia followed for more than 5 years. Am J Gastroenterol 97:1346–1351

    Article  PubMed  CAS  Google Scholar 

  10. Blam ME, Delfyett W, Levine MS, Metz DC, Katzka DA (2002) Achalasia: A disease of varied and subtle symptoms that do not correlate with radiographic findings. Am J Gastroenterol 97:1916–1923

    Article  PubMed  Google Scholar 

  11. Ben-Meir A, Urbach DR, Khajanchee YS, Hansen PD, Swanstrom LL (2001) Quality of life before and after laparoscopic Heller myotomy for achalasia. Am J Surg 181:471–474

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This research was supported in part by the Canadian Institutes of Health Research. Dr. Urbach is the Tyco Chair of Minimally Invasive Surgery at the University Health Network.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Julie L. Harnish.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harnish, J.L., Darling, G.E., Diamant, N.E. et al. Patient-centered measures for achalasia. Surg Endosc 22, 1290–1293 (2008). https://doi.org/10.1007/s00464-007-9612-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-007-9612-2

Keywords

Navigation